Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Acquired rare recurrent <i>EGFR</i> mutations as mechanisms of resistance to Osimertinib in lung cancer and <i>in silico</i> structural modelling.
PaperCitations, authors & open-access status
Acquired rare recurrent <i>EGFR</i> mutations as mechanisms of resistance to Osimertinib in lung cancer and <i>in silico</i> structural modelling. is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 20 citations, 2020 year and green oa status.
20
Citations
2020
Year
green
OA Status